ITSCRC2021: Growth control by the TSC-mTOR pathway and therapeutic strategies for TSC

Dr Brendan Manning (Department of Molecular Metabolism, Harvard University) presents his research on how the TSC m-TOR pathway controls how much cells grow, and how knowledge of this pathway has led to different therapies for individuals living with TSC.
Brendan presents his research on how the TSC m-TOR pathway controls how much cells grow, and how knowledge of this pathway has led to different therapies for individuals living with TSC.

[@josephandhopelopez8492]

Thank you so much for taking the time to explain the data in your slides.

[@naziragha903]

Great information 🐱